There are about 105 clinical studies being (or have been) conducted in Sri Lanka. The country of the clinical trial is determined by the location of where the clinical research is being studied. Most studies are often held in multiple locations & countries.
Development of a new MS-based biomarker for the early and sensitive diagnosis of Tyrosinemia type 1 from blood (plasma)
Development of a new MS-based biomarker for the early and sensitive diagnosis of Mannosidosis disease from blood (plasma)
Development of a new MS-based biomarker for the early and sensitive diagnosis of Homozygous familial Hypercholesterolemia from blood
Development of a new MS-based biomarker for the early and sensitive diagnosis of Hyaline fibromatosis syndrome from the blood
Development of a new mass spectrometry-based biomarker for the ear-ly and sensitive diagnosis of the Creatine Deficiency Syndromes from dry-blood-spot sample
ACSSLAP is the first island wide audit project in Sri Lanka on ACS.
Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Cystinosis disease from the blood
Development of a new mass spectrography-based biomarker for the early and sensitive diagnosis of Fabry disease from the blood
Development of a new MS-based biomarker for the early and sensitive diagnosis of Gilbert disease from blood
Development of a new MS-based biomarker for the early and sensitive diagnosis of Hypophosphatasia disease from plasma